[MAS-like lesions and SIADH caused by bortezomib in the treatment of multiple myeloma : three cases report and literature review]

Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):75-77. doi: 10.3760/cma.j.issn.0253-2727.2022.01.015.

[Article in Chinese]

Authors

L L Wang¹, C Y Geng¹, Y R Zhang¹, Y Wu¹

Affiliation

¹ Department of Hematology, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.

PMID: 35231998
PMCID: PMC8980669
DOI: 10.3760/cma.j.issn.0253-2727.2022.01.015

No abstract available

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Agents* / adverse effects
Antineoplastic Agents* / therapeutic use
Bortezomib* / adverse effects
Bortezomib* / therapeutic use
Humans
Inappropriate ADH Syndrome* / chemically induced
Multiple Myeloma* / drug therapy

Substances

Antineoplastic Agents
Bortezomib